You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
Prayuenyong P, Baguley DM, Kros CJ, et al. (2021) Preferential Cochleotoxicity of Cisplatin. Frontiers in Neuroscience. 15: 695268 |
Jiang M, Li H, Johnson A, et al. (2019) Inflammation up-regulates cochlear expression of TRPV1 to potentiate drug-induced hearing loss. Science Advances. 5: eaaw1836 |
Kros CJ, Steyger PS. (2018) Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies. Cold Spring Harbor Perspectives in Medicine |
Jiang M, Taghizadeh F, Steyger PS. (2017) Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity. Frontiers in Cellular Neuroscience. 11: 362 |
Jiang M, Karasawa T, Steyger PS. (2017) Aminoglycoside-Induced Cochleotoxicity: A Review. Frontiers in Cellular Neuroscience. 11: 308 |
Garinis AC, Liao S, Cross CP, et al. (2017) Effect of gentamicin and levels of ambient sound on hearing screening outcomes in the neonatal intensive care unit: A pilot study. International Journal of Pediatric Otorhinolaryngology. 97: 42-50 |
Adler HJ, Anbuhl KL, Atcherson SR, et al. (2017) Community network for deaf scientists. Science (New York, N.Y.). 356: 386-387 |
Steyger PS. (2017) Is Auditory Synaptopathy a Result of Drug-Induced Hearing Loss? The Hearing Journal. 70: 8-9 |
Koo JW, Quintanilla-Dieck L, Jiang M, et al. (2015) Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity. Science Translational Medicine. 7: 298ra118 |
Karasawa T, Steyger PS. (2015) An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicology Letters. 237: 219-27 |